cancer patients

Belong.Life, a leading global provider of high-engagement patient communities and care platforms, announced the launch of Dave, the world's first…

Data from new study presented at the 2022 San Antonio Breast Cancer Symposium builds on groundbreaking data presented at the 2021 Symposium…

Massive Bio, a leader in AI-powered cancer clinical trial enrollment, announced a strategic partnership with Perthera.ai, a pioneer in connecting…

Three senior executives join Massive Bio, which is expanding its operations in Europe with Series B investments Massive Bio, which uses its…

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric clinical trial enrollment for oncology, and…

Incorporating expert cancer information from Macmillan Cancer Support, Accord Healthcare launches new app for cancer patients – more pertinent than…

Deep Lens announced a collaboration that will integrate Deep Lens’ artificial intelligence (AI)-based clinical trial screening and matching solution…

The new registration module facilitates expanded access to novel therapies for patients with advanced cancer while accelerating the generation of…

Proceeds to Expand Cancer Patients' Access to Advanced Treatments Using Artificial Intelligence TrialJectory, an AI-powered technology platform…